Healthcare provider profile · identity verified

Roxana Delmonte, DNP

Nurse Practitioner · WESTON, FL · NPI 1326630724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	427	151
Amlodipine Besylate	Amlodipine Besylate	235	76
Atorvastatin Calcium	Atorvastatin Calcium	190	60
Losartan Potassium	Losartan Potassium	186	55
Levothyroxine Sodium	Levothyroxine Sodium	182	56
Vitamin D2	Ergocalciferol (Vitamin D2)	135	65
Metformin Hcl	Metformin Hcl	103	37
Lisinopril	Lisinopril	101	30
Pantoprazole Sodium	Pantoprazole Sodium	98	35
Celecoxib	Celecoxib	89	61
Diclofenac Sodium	Diclofenac Sodium	87	63
Azithromycin	Azithromycin	86	74
Tamsulosin Hcl	Tamsulosin Hcl	83	28
Omeprazole	Omeprazole	73	27
Ciprofloxacin Hcl	Ciprofloxacin Hcl	70	61
Metformin Hcl Er	Metformin Hcl	63	23
Alprazolam	Alprazolam	61	20
Gabapentin	Gabapentin	61	22
Methylprednisolone	Methylprednisolone	59	57
Metoprolol Tartrate	Metoprolol Tartrate	59	22
Metoprolol Succinate	Metoprolol Succinate	56	18
Eliquis	Apixaban	54	15
Ibuprofen	Ibuprofen	53	23
Temazepam	Temazepam	52	12
Carvedilol	Carvedilol	49	16
Ezetimibe	Ezetimibe	48	17
Simvastatin	Simvastatin	47	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	11
Triamcinolone Acetonide	Triamcinolone Acetonide	46	26
Meloxicam	Meloxicam	43	29
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Azelastine Hcl	Azelastine Hcl	41	20
Ozempic	Semaglutide	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	16
Furosemide	Furosemide	36	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	34
Trazodone Hcl	Trazodone Hcl	35	16
Hydrochlorothiazide	Hydrochlorothiazide	33	15
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Atenolol	Atenolol	31	11
Allopurinol	Allopurinol	30	11
Famotidine	Famotidine	30	14
Mupirocin	Mupirocin	30	25
Sertraline Hcl	Sertraline Hcl	30	14
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Clonazepam	Clonazepam	25	suppressed
Glipizide	Glipizide	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	14
Lactulose	Lactulose	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Valsartan	Valsartan	23	suppressed
Baclofen	Baclofen	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	20	20
Farxiga	Dapagliflozin Propanediol	19	suppressed
Amoxicillin	Amoxicillin	18	18
Donepezil Hcl	Donepezil Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Ketoconazole	Ketoconazole	17	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Linzess	Linaclotide	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Synthroid	Levothyroxine Sodium	15	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error